Male diabetic rats also had lower seminal vesicle and ventral prostate gland weight compared with normal rats. No difference was found in hMSC or preadipocyte proliferation in the presence of DHT, suggesting that DHT only inhibits the uptake of lipids into adipocytes and not other hMSC differentiation.25 DHT inhibited the differentiation of hMSCs into adipocytes, as well as lipid accumulation in existing adipocytes.
The LAD was isolated and placed in either prostaglandin or potassium chloride (KCl), another contracting agent, and testosterone. This study tested the effect of endothelial denudation as well as washing the vessels with either Krebs–Henseleit bicarbonate (KHB), or N‐nitro‐l‐arginine methyl ester (l‐NAME). Deenadayalu et al18 performed a similar study using the left anterior descending (LAD) coronary arteries of swine hearts. Statistical significance was observed at both 1 and 10 μmol/L of testosterone, and there was no difference between the groups with and without endothelium.16 This suggests that testosterone has a direct smooth muscle–relaxing effect and does not require endothelium to induce vasodilation. After 7 minutes in prostaglandin, arteries were washed and exposed to testosterone or control solution. Effects of a therapy on blood vessels that have been subjected to endothelial denudation would suggest that the drug is working through an endothelium‐independent and NO‐mediated‐independent mechanism, such as directly on the tunica media (smooth muscle layer) of an artery. There is little information regarding the mechanism by which testosterone exerts its cardioprotective effect regarding ischemic injury; thus, more research is required.
It is responsible for muscle mass, regulating sex drive, bone density, and also heart health. This review discusses the molecular pathways and clinical implications of T in the vascular system. At the vascular level, the key effect of T is the vasorelaxation. Federal government websites often end in .gov or .mil. An official website of the United States government
The authors also found higher vascular and all-cause mortality among men with low plasma T levels when compared with men without androgen deficiency. In lieu of such data, small randomized trials to date have been performed that evaluate CVD risk factors rather than events as study endpoints, and these demonstrate mixed effects of TRT. Testosterone prescriptions have risen steadily and sharply in the USA despite a lack of clear understanding of the relationship between androgens and cardiovascular disease. Finally, it is well known that the serum levels of Tes fall markedly with increasing age in otherwise normal men, and there is increasing evidence that Tes replacement therapy significantly improves cardiovascular and metabolic functions in hypogonadal aging men (28, 33, 34, 53, 62).
In contrast, the A-ring bends 90° relative to the steroid nucleus when the C5 hydrogen is β/cis oriented, as in the case of 5β-reduced androgens such as 5β-DHT (see structural conformations in Fig. 2). We have observed that the A-ring of the steroid nucleus is planar in the structure of Tes and in the α/trans configuration at C5 of reduced metabolites such as 5α-DHT. Nevertheless, the dramatic difference in vasorelaxing potency between Tes and its dihydro-metabolites deserves further consideration, based on their different structural conformations. However, to our knowledge, there is no information available on the plasma concentrations of 5β-DHT; consequently, further research is urgently needed to determine the range of normal plasma concentrations of 5β-DHT. Whereas the circulating plasma concentration of Tes in adult men ranges 11–36 nmol/l, its 5α-reduced metabolite (5α-DHT) is present in the plasma at levels of only about 10% that of Tes (1.0–2.9 nmol/l). As a nonaromatizable dihydro-androgen metabolite of Tes, 5α-DHT has been frequently used as a tool to verify that the aromatization of Tes to estrogen is not required for this androgen to produce vasorelaxation (3, 8, 10, 64, 73).
The experimental literature shows that testosterone causes beneficial cardiovascular effects with regard to APD and EADs and decreases QTc interval length. Researchers hypothesized that androgen‐deficient mice (testosterone or DHT) would exhibit ventricular repolarization characteristics similar to female mice, whereas mice with physiological levels of testosterone, achieved endogenously or by supplementation, would exhibit comparatively shorter ventricular repolarization times. Brouilette et al7 examined the effects of androgens on ventricular repolarization in genetically low‐testosterone mice and mice with genetically normal physiological levels of testosterone. Further, observational data suggest that men with low circulating T levels may be at greater risk for cardiovascular disease (CVD). Cardiovascular risk increases in men with age in tandem with declining endogenous testosterone (T) production. In this article, we review current literature in an attempt to better understand what it suggests is the true relationship between testosterone and cardiovascular disease.
Studies have suggested that low levels of testosterone may have a connection with an increased risk of cardiovascular problems such as stroke and heart disease. Because of the increase in the number of prescriptions and use of testosterone in adult males for the treatment of hypogonadism, low libido, and weakness,1 an investigation of the effects of testosterone on the cardiovascular system in basic science studies was carried out. To the contrary, recent literature has raised concern for increased cardiovascular disease in certain groups of men receiving testosterone therapy. There has been longstanding concern that testosterone replacement therapy may increase cardiovascular risk, as well as the risk of thromboembolic disease. Does testosterone replacement therapy in middle-aged and older men with hypogonadism cause increased overall cardiovascular risk?
An alternative approach, employed to examine the association between T levels over time and CVD, was a nested case–control study within the Baltimore Longitudinal Study of Aging and the Multiple Risk Factors Intervention Trial . Additional longitudinal studies have similarly found that neither high nor low T levels predict incident myocardial infarction 14–16. In contrast, men in the highest quartile of serum T in the MrOS study had the lowest incidence of CVD events over 5 years of follow-up . These longitudinal analyses, therefore, relate endogenous T levels to the development of disease over time. This type of study design generally entails measurement of a single, or possibly two, serum T levels in participants, whose health trajectories are then followed over the ensuing years. Similar to these cross-sectional analyses, longitudinal data have shown mixed findings, although most studies have not demonstrated a relationship between circulating T levels and incident CVD.

Gender: Female

Social links